Inactief instrument

Andere talen Neurotrope, Inc.

Aandelen

NTRP

US64129T2078

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Neurotrope, Inc. completed the spin-off of Neurotrope Bioscience, Inc.	02-12-20
Metuchen Pharmaceuticals LLC completed the acquisition of Neurotrope, Inc. from Intracoastal Capital LLC and others in a reverse merger transaction.	01-12-20
NEUROTROPE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	25-11-20
NEUROTROPE, INC. : Other Events (form 8-K)	24-11-20
NEUROTROPE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	20-11-20
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	09-11-20
Neurotrope, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	09-11-20
Neurotrope, Inc Announces Dosing of the First Patient in Its Ongoing, Long-Term Phase 2 Study of Bryostatin-1 for the Treatment of Alzheimer's Disease	06-10-20
NEUROTROPE, INC. : Other Events (form 8-K)	30-09-20
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	30-09-20
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	10-08-20
Neurotrope, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	10-08-20
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	29-07-20
NEUROTROPE, INC. : Other Events (form 8-K)	24-07-20
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	24-07-20
Neurotrope : Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the National Cancer Institute Trial for Childhood Leukemia	15-06-20
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	12-06-20
Neurotrope, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	12-06-20
Bryologyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1	10-06-20
NEUROTROPE, INC. : Regulation FD Disclosure, Other Events (form 8-K)	28-05-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Neurotrope, Inc.

Aandelen

NTRP

US64129T2078

Andere talen

Filters